Jack Dean

Jack Dean

Directeur/Membre du Conseil chez ACURX PHARMACEUTICALS, INC.

Fortune : 44 409 $ au 31/05/2024

82 ans
Health Technology
Commercial Services
Consumer Services

Profil

Jack Hugh Dean was the founder of Dipexium Pharmaceuticals, Inc. (founded in 2010) and held the title of Director from 2010 to 2014.
He is currently working as a Director at ReSearch Pharmaceutical Services LLC since 2008, as an Independent Director at Acurx Pharmaceuticals, Inc. since 2021, as the President of Drug Development Advisors LLC since 2006, as a Trustee at ILSI Health & Environmental Sciences Institute since 1994, and as a Professor at the University of Arizona College of Pharmacy since 2006.
In his former positions, Dr. Dean worked as the Global Director-Preclinical Development at Sanofi from 1988 to 2006, as a Director at Sanofi-Synthelabo, Inc., as the Director of Sterling Winthrop Pharmaceuticals Research Center from 1990 to 1992, as the Director-Department of Immunology at Litton Bionetics, Inc. from 1975 to 1979, as the Vice President-Drug Safety at Sterling Winthrop, Inc. from 1989 to 1992, as the Head-National Toxicology Program at the National Institutes of Health from 1982 to 1988, as the President-US Science & Medical Affairs at Sanofi-Aventis U.S.
LLC from 1988 to 2006, as the Head-Immunotoxicology Section at The National Institute of Environmental Health Sciences from 1982 to 1988, and as the Head-Cellular & Molecular Toxicology Department at The Hamner Institutes for Health Sciences from 1982 to 1988.
Dr. Dean's education includes undergraduate and graduate degrees from The California State University and a doctorate degree from the University of Arizona College of Medicine (conferred in 1972).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/06/2024 17 693 ( 0,11% ) 44 409 $ 31/05/2024

Postes actifs de Jack Dean

SociétésPosteDébut
ACURX PHARMACEUTICALS, INC. Directeur/Membre du Conseil 24/06/2021
Directeur/Membre du Conseil 12/05/2008
University of Arizona College of Pharmacy Corporate Officer/Principal 01/01/2006
ILSI Health & Environmental Sciences Institute Directeur/Membre du Conseil 01/01/1994
Drug Development Advisors LLC President 01/01/2006
Tous les postes actifs de Jack Dean

Anciens postes connus de Jack Dean

SociétésPosteFin
Directeur Technique/Scientifique/R&D 01/01/2006
SANOFI Corporate Officer/Principal 01/01/2006
Sterling Winthrop Pharmaceuticals Research Center Directeur/Membre du Conseil 01/01/1992
Corporate Officer/Principal 01/01/1988
░░░ ░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Jack Dean

Formation de Jack Dean

The California State University Graduate Degree
University of Arizona College of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jack Dean

Relations

100 +

Relations au 1er degré

17

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
SANOFI

Health Technology

ACURX PHARMACEUTICALS, INC.

Health Technology

Entreprise privées12

Commercial Services

Health Technology

Sterling Winthrop Pharmaceuticals Research Center

Commercial Services

Commercial Services

Government

Drug Development Advisors LLC

Consumer Durables

Sanofi-Synthelabo, Inc.

Health Technology

Health Technology

ILSI Health & Environmental Sciences Institute

Litton Bionetics, Inc.

Voir les connexions sociétés